keyword
https://read.qxmd.com/read/38461113/risk-stratification-model-for-the-pharmaceutical-care-of-oncology-patients-with-solid-or-hematologic-neoplasms
#21
JOURNAL ARTICLE
Beatriz Bernardez, Irene Mangues Bafalluy, Virginia Martínez Callejo, Juan José Fernández Ávila, Jose Antonio Marcos Rodríguez, Maria Angeles Parada Aradilla, María José Martínez Bautista
OBJECTIVE: We aimed to develop of a risk stratification model for the pharmaceutical care (PC) of patients with solid or hematologic neoplasms who required antineoplastic agents or supportive treatments. METHOD: The risk stratification model was collaboratively developed by oncology pharmacists from the Spanish Society of Hospital Pharmacy (SEFH). It underwent refinement through three workshops and a pilot study. Variables were defined, grouped into four dimensions, and assigned relative weights...
March 8, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38461112/analysis-of-retreatment-with-monoclonal-antibodies-in-chronic-episodic-migraine-real-world-data
#22
JOURNAL ARTICLE
Patricia García-Lloret, Mercedes Galván-Banqueri, María de Las Aguas Robustillo-Cortés, María Fernández-Recio
OBJECTIVE: To analyze the response to retreatment in patients with chronic/episodic migraine who discontinued therapy with erenumab/fremanezumab after 1 year of treatment. METHODS: Observational, retrospective, single-center, multidisciplinary study in patients with chronic/episodic migraine who received therapy with erenumab/fremanezumab for at least 1 year and discontinued it after achieving an adequate response (optimization). The evaluation of the response after retreatment included the following variables: DMM, MIDAS, and HIT-6 scales at the beginning of retreatment and 3 months later...
March 8, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38458852/telematic-interview-in-telepharmacy-consensus-document-for-farmacotherapeutic-monitoring-and-informed-drug-delivery
#23
JOURNAL ARTICLE
Sara Barbadillo-Villanueva, Vera Áreas Del Aguila, María de Las Aguas Robustillo-Cortés, Mercedes Gimeno-Gracia, Elena Sánchez Yáñez, Marta Hermenegildo-Caudevilla, Herminia Navarro Aznárez, Alicia Lázaro López, Esther Vicente, Emilio Monte-Boquet
Telepharmacy is defined as the practice of remote pharmaceutical care, using information and communication technologies. Given its growing importance in outpatient pharmaceutical care, the Spanish Society of Hospital Pharmacy developed a consensus document, "Guía de entrevista telemática en atención farmacéutica," as part of its strategy for the development and expansion of telepharmacy, with key recommendations for effective pharmacotherapeutic monitoring and informed dispensing and delivery of medications through telematic interviews...
March 7, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38448361/concordance-between-two-models-of-stratification-for-patients-living-with-hiv-infection-to-providing-pharmaceutical-care
#24
JOURNAL ARTICLE
Ramón Morillo-Verdugo, Sebastián Parra-Zuñiga, María Alvarez de Sotomayor-Paz, Enrique Contreras-Macias, Carmen Victoria Almeida-González, María de Las Aguas Robustillo-Cortes
OBJECTIVE: To determine the degree of agreement of 2 differents stratification models for pharmaceutical care to people living with HIV. METHODS: This was a single-center observational prospective cohort study of patients with regular follow-up in pharmaceutical care consultations according to the Capacity-Motivation-Opportunity methodology, conducted between January 1 and March 31, 2023. Patients received the pharmacotherapeutic interventions applied routinely to ambulatory care patients according to this model...
March 5, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38448360/real-world-persistence-with-dolutegravir-lamivudine-versus-bictegravir-emtricitabina-tenofovir-alafenamide-among-people-with-hiv
#25
JOURNAL ARTICLE
Lorena Martín-Zaragoza, Javier Sánchez-Rubio-Ferrández, Alberto Onteniente-González, Marcos Gómez-Bermejo, Sergio Julio Rodríguez-Álvarez, Alfonso Monereo-Alonso, Teresa Molina-García
OBJETIVES: The main objective was to compare the persistence between dolutegravir/lamivudine (DTG/3TC) and bictegravir/emtricitabine/tenofovir-alafenamide (BIC/FTC/TAF) and to analyze reasons for discontinuation. METHODS: We conducted a retrospective, non-interventional, descriptive and longitudinal study. All human immunodeficiency virus (HIV) patients over 18 years treated with DTG/3TC or BIC/FTC/TAF in our center were included. Persistence after first year was compared using the χ2 test...
March 5, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38423945/perceived-quality-of-life-in-patients-with-psoriasis-treated-with-interleukin-17-and-23-inhibitors
#26
JOURNAL ARTICLE
Bárbara Anguita-Montenegro, Vera Lucía Areas-Del Águila, Elena Palacios-Moya, Mónica García-Arpa, María Prado Sánchez-Caminero, María Luque-Jiménez
OBJECTIVE: To determine the effectiveness in terms of quality of life perceived by adult patients with moderate/severe plaque psoriasis treated with interleukin 17 or 23 inhibitors and to identify associated factors. METHOD: Cross-sectional observational study including adult patients diagnosed with moderate/severe plaque psoriasis treated with interleukin 17 or 23 inhibitors for at least 12 or 16 weeks in follow-up, respectively. RESULTS: Forty-one patients were included: 65% male, median age 54 years (SD=13)...
February 28, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38341366/exploring-the-impact-of-pharmacogenetics-on-personalized-medicine-a-systematic-review
#27
REVIEW
Laura Amaro-Álvarez, Jaime Cordero-Ramos, Miguel Ángel Calleja-Hernández
INTRODUCTION: Pharmacogenetics evaluates how genetic variations influence drug responses. Nowadays, genetic tests have advanced, becoming more affordable, and its integration is supported by stronger clinical evidence. Guidelines such as those from CPIC (Clinical Pharmacogenetics Implementation Consortium) and resources like PharmGKB facilitate genotype-based prescribing; and organizations like the FDA promote genetic testing before initiating certain medications. Preventive pharmacogenetic panels seem promising, but further research on biomarkers and diverse populations is needed...
February 9, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38336554/retrospective-study-of-home-antibiotic-infusion-therapy-in-elastomeric-infusion-pumps
#28
JOURNAL ARTICLE
Sara Ferro Rodríguez, Yelco Chantres Legaspi, Eva María Romay Lema, Blanca Ayuso García, Paloma Castellano Copa, Pedro Peinó Camba, Andrea Barcia Losada, Cristina Rodríguez Díaz
OBJECTIVES: To describe the experience of home antibiotic infusion therapy using elastomeric infusion pumps, administered to patients admitted to the Home Hospitalization Unit of a tertiary hospital for three years and to analyse clinical evolution and mortality. METHOD: Retrospective observational study. The medical history of the patients included in the study was reviewed. Information was obtained on personal history, antimicrobial therapy received and clinical evolution...
February 8, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38336553/analysis-of-antiretroviral-therapy-interruption-in-people-living-with-hiv-during-the-2010-2021-period
#29
JOURNAL ARTICLE
Enrique Contreras-Macías, Antonio Gutiérrez-Pizarraya, Juan Antonio Pineda-Vergara, Ramón Morillo-Verdugo
INTRODUCTION: In the context of the advancement of antiretroviral therapy and as the characteristics of people living with HIV progress toward an ageing population, understanding the causes of treatment interruption becomes crucial. The aim of the study was to determine the change in reasons for antiretroviral treatment discontinuation for 12 years. Secondarily, compare annual antiretroviral regimen discontinuation rate and factors associated. METHODS: We conducted an analysis using data from people living with HIV who were receiving antiretroviral therapy and discontinued it for any reason...
February 8, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38336552/validated-medication-adherence-questionnaires-and-associated-factors-in-chronic-patients-systematic-review
#30
REVIEW
Aldana Intilangelo, Sofía Majic, Valeria Palchik, María Luz Traverso
OBJECTIVE: To identify validated questionnaires to assess medication adherence, and its associated factors, in adult patients with chronic pathologies. METHOD: A systematic review of scientific publications that describe validated medication adherence questionnaires in PubMed and Scopus was carried out during May 2022. The search strategy combined the MeSH Heading "Medication adherence" with the keywords: "Questionnaire" and "Validation"; adding "Spanish" to rescue questionnaires in our language...
February 8, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38233237/detection-and-reduction-of-errors-in-parenteral-nutrition-compounding-through-gravimetric-and-product-control
#31
JOURNAL ARTICLE
Daniel Gómez-Costas, Rosa María Romero-Jiménez, Maria Elena Lobato-Matilla, Raquel Culebras, Judy Alejandra González, Sergio Herrero-Bermejo, Ana María Herranz-Alonso, María Sanjurjo-Saez
OBJECTIVE: To analyze the errors in the preparation of parenteral nutrition in a Pharmacy Service, detected through an already consolidated gravimetric and product quality control, and compare them with those detected during the initial years of implementing this quality control. METHODS: All errors detected through quality control in the compounding of pediatric and adult parenteral nutritions between 2019 and 2021 were prospectively analyzed. This quality control consisted of 3 sequential processes: a visual check, a gravimetric control, and a product control...
January 16, 2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38200616/tisbe-a-public-web-platform-for-the-consensus-based-explainable-prediction-of-developmental-toxicity
#32
JOURNAL ARTICLE
Fabrizio Mastrolorito, Maria Vittoria Togo, Nicola Gambacorta, Daniela Trisciuzzi, Viviana Giannuzzi, Fedele Bonifazi, Antonella Liantonio, Paola Imbrici, Annamaria De Luca, Cosimo Damiano Altomare, Fulvio Ciriaco, Nicola Amoroso, Orazio Nicolotti
Despite being extremely relevant for the protection of prenatal and neonatal health, the developmental toxicity (Dev Tox) is a highly complex endpoint whose molecular rationale is still largely unknown. The lack of availability of high-quality data as well as robust nontesting methods makes its understanding even more difficult. Thus, the application of new explainable alternative methods is of utmost importance, with Dev Tox being one of the most animal-intensive research themes of regulatory toxicology. Descending from TIRESIA (Toxicology Intelligence and Regulatory Evaluations for Scientific and Industry Applications), the present work describes TISBE (TIRESIA Improved on Structure-Based Explainability), a new public web platform implementing four fundamental advancements for in silico analyses: a three times larger dataset, a transparent XAI (explainable artificial intelligence) framework employing a fragment-based fingerprint coding, a novel consensus classifier based on five independent machine learning models, and a new applicability domain (AD) method based on a double top-down approach for better estimating the prediction reliability...
January 10, 2024: Chemical Research in Toxicology
https://read.qxmd.com/read/38185507/-translated-article-consolidating-and-advancing-the-progress-made
#33
EDITORIAL
Teresa Bermejo Vicedo, Maria Queralt Gorgas Torner
No abstract text is available yet for this article.
2024: Farmacia Hospitalaria
https://read.qxmd.com/read/38184070/role-of-the-clinical-radiopharmacist-in-patient-safety-during-myocardial-perfusion-imaging-with-vasodilator-stress-agents
#34
JOURNAL ARTICLE
C Salgado-Garcia, A Moreno-Ballesteros, P Guardia-Jimena, E Sanchez-de-Mora, A C Rebollo-Aguirre, A Ramirez-Navarro, A Santos-Bueno, A Jimenez-Heffernan
AIM: To assess the radiopharmacist's role in a multidisciplinary team focused on the contraindications of regadenoson in order to ensure the safe use of pharmacologic vasodilator stress agents in patients undergoing SPECT-MPI. METHODS: We ambispectively studied its safe use in 1905 patients (54.1% female, mean age: 66.6±11.7 years, range: 20-95 years). Sex, age, medical history, medications, drug allergies, and contraindications for stress testing were registered together with recommendations for the nuclear physician in charge...
January 4, 2024: Revista española de medicina nuclear e imagen molecular
https://read.qxmd.com/read/38160121/-analysis-of-the-evolution-of-outpatient-pharmaceutical-care-in-hospital-pharmacy-services-in-spain-after-the-implementation-and-development-of-the-mapex-initiative
#35
JOURNAL ARTICLE
R Morillo Verdugo, E Vicente Escrig, M Murillo Izquierdo, O Ibarra Barrueta, P Taberner Bonastre, C M Fernández-Llamazares
INTRODUCTION AND OBJECTIVE: In 2015, the Spanish Society of Hospital Pharmacy (SEFH) launched the Strategic Map for Outpatient Pharmaceutical Care (MAPEX), with the purpose of adapting the activity offered in Hospital Pharmacy outpatient clinics to the new healthcare context. The aim of the present study was to analyse the evolution of outpatient pharmaceutical care in Hospital Pharmacy Services in Spain in the period 2016-2021 after the implementation and development of the MAPEX initiative...
December 29, 2023: Journal of Healthcare Quality Research
https://read.qxmd.com/read/38151407/-translated-article-analysis-2016-2021-of-the-development-of-the-mapex-outpatient-pharmaceutical-care-project-by-regions-in-spain
#36
JOURNAL ARTICLE
Esther Vicente-Escrig, Pilar Taberner Bonastre, Olatz Ibarra Barrueta, Manuel Murillo Izquierdo, Cecilia M Fernández-Llamazares, Ramón Morillo-Verdugo
OBJECTIVE: To analyse the evolution of the MAPEX Project (Strategic Map of Pharmaceutical Care for Outpatients) byregions in Spain, through the results of the comparative situation survey between 2016 and 2021. METHODS: A committee of national experts belonging to the Spanish Society of Hospital Pharmacy prepared the MAPEX Survey on the situation of Outpatient Units, which consisted of 43 specific questions on aspects related to structure, context, integration, processes, results and training, teaching, and investigation...
December 26, 2023: Farmacia Hospitalaria
https://read.qxmd.com/read/38150850/-new-tools-for-medication-review-drp-in-patients-treatment-with-proton-pump-inhibitors
#37
JOURNAL ARTICLE
Salvador Gutiérrez-Igual, Rut Lucas-Domínguez, Alberto Martí Rodrigo, Isabel Romero Crespo, M Carmen Montesinos Mezquita
OBJECTIVE: To analyze, using the medication review program, Revisem®, the prevalence of drug-related problems (DRP) in patients in the province of Valencia who were on active treatment with proton pump inhibitors (PPI) in 2022. DESIGN: Descriptive and retrospective observational study. MATERIAL AND METHODS: The pharmacotherapeutic history of 295 patients was analyzed following the criteria proposed by the Pharmaceutical Care Network Europe, using the Revisem® digital platform of the Muy Ilustre Colegio Oficial de Farmacéuticos (MICOF)...
December 26, 2023: Atencion Primaria
https://read.qxmd.com/read/38148256/-translated-article-design-of-a-panel-of-indicators-for-antibiotic-stewardship-programs-in-the-emergency-department
#38
JOURNAL ARTICLE
Jesús Ruiz-Ramos, María Rosario Santolaya-Perrín, Juan González-Del-Castillo, Francisco Javier Candel, Alejandro Martín-Quirós, Joaquín López-Contreras-González, Agustín Julián-Jiménez, Ana Suárez-Lledó-Grande
OBJECTIVE: To develop a panel of indicators to monitor antimicrobial stewardship programs activity in the emergency department. METHODS: A multidisciplinary group consisting of experts in the management of infection in emergency departments and the implementation of antimicrobial stewardship programs (ASP) evaluated a proposal of indicators using a modified Delphi methodology. In the first round, each expert classified the relevance of each proposed indicators in two dimensions (healthcare impact and ease of implementation) and two attributes (prioritisation level and frequency)...
December 25, 2023: Farmacia Hospitalaria
https://read.qxmd.com/read/38148255/-translated-article-risk-sharing-agreement-based-on-health-outcomes-for-the-treatment-of-moderate-severe-psoriasis-with-certolizumab-pegol
#39
JOURNAL ARTICLE
Andrés Navarro Ruiz, Fernando Toledo Alberola, Susana Aceituno
OBJECTIVE: To provide evidence of the effectiveness of certolizumab pegol (CZP) in real clinical practice in adult patients with moderate-to-severe plaque psoriasis (PsO) in the context of a risk-sharing agreement (RSA). METHODS: Retrospective observational study based on variables collected in the RSA for treatment with CZP of adult patients with moderate-severe plaque PsO. Ten Spanish hospitals where the RSA was implemented participated. The percentage of patients who achieved the target clinical response of the RSA at the follow-up visit (week 16) was evaluated: absolute Psoriasis Area and Severity Index (PASI) value ≤3 for biologic naïve population, and ≤5 in case of previous failure to a single biologic drug...
December 25, 2023: Farmacia Hospitalaria
https://read.qxmd.com/read/38114413/abemaciclib-as-adjuvant-treatment-for-high-risk-early-breast-cancer
#40
RANDOMIZED CONTROLLED TRIAL
Ana Ganfornina Andrades, Silvia Fénix Caballero, Alba Salguero Olid, Emilio Jesús Alegre Del-Rey
OBJECTIVE: To adapt the GHEMA report of abemaciclib, an inhibitor of cyclin-dependent kinases 4 and 6. European Medicines Agency authorisation (April 2022) includes, in combination with endocrine therapy, the adjuvant treatment of adult patients with hormone receptor positive, human epidermal growth factor receptor 2 negative, node-positive, early breast cancer at high risk of recurrence. METHOD: The efficacy and safety of abemaciclib were evaluated in a randomized, open-label and multicenter phase III study...
2024: Farmacia Hospitalaria
keyword
keyword
85087
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.